{
  "success": true,
  "pagesUsed": [
    0,
    1,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    41,
    42,
    43,
    44,
    45,
    46
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Atezolizumab",
        "type": {
          "id": "4de8bc4d-7395-49f4-b55b-b74d458cc443",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "5e6f81c5-7076-419d-87e5-bd09c685c580",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Anti-PD-L1 antibody (MPDL3280A) administered in combination with paclitaxel.",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Placebo",
        "type": {
          "id": "00bd386d-6cdf-42e2-aeb1-dea86afb88ba",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "ebd92884-2b6e-4818-9d2e-e5061f359268",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo consisting of the vehicle without the antibody.",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Paclitaxel",
        "type": {
          "id": "3eb4f308-ee61-44b4-8fc2-ca69aea89ebf",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "c193ce92-e8ed-439c-917c-f61c11e53c1e",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Standard chemotherapy administered as background therapy in both study arms.",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Dexamethasone",
        "type": {
          "id": "28358aed-cdae-4d55-8dbc-a98311b277f2",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "63ae1d56-7c90-48d1-9b8c-478e874df5ff",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required premedication for paclitaxel to prevent hypersensitivity reactions.",
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Diphenhydramine",
        "type": {
          "id": "7e09582e-d8b3-4643-bde0-46008de21d0b",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "99694a55-60eb-428b-990e-844bf479b566",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required premedication for paclitaxel (antihistamine)."
      },
      {
        "id": "int_6",
        "name": "Cimetidine",
        "type": {
          "id": "5b6f3dec-ba70-49c1-9ab4-b9c5fad1c67e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "7d5f6e45-44d5-44eb-a4d4-4edceda09bf7",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Required premedication for paclitaxel (H2 receptor antagonist)."
      },
      {
        "id": "int_7",
        "name": "Ranitidine",
        "type": {
          "id": "8d3ba570-1a2f-4c44-adff-6260b4beb806",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "dc4059be-0d60-480c-9009-7aefa507923a",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Alternative required premedication for paclitaxel (H2 receptor antagonist)."
      },
      {
        "id": "int_8",
        "name": "Chinese traditional medicines",
        "type": {
          "id": "5f4daeaf-ace7-4891-994c-e63b43c1e2f8",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "756eb091-8f78-463b-846c-1fbe5c54b8ab",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted for China Population if last administration was at least 2 weeks prior to randomisation."
      },
      {
        "id": "int_9",
        "name": "Systemic immunosuppressive medications",
        "type": {
          "id": "c0af40d1-f7cd-4425-bb1e-2f51ea9a3546",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "1d338177-d3be-42f3-8e1b-fb5bbc95839d",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 2 weeks prior to randomisation (includes cyclophosphamide, azathioprine, cyclosporine, methotrexate, thalidomide, and anti-TNF agents)."
      },
      {
        "id": "int_10",
        "name": "Live, attenuated vaccine",
        "type": {
          "id": "d24f7d63-edf6-41da-8687-a41c7fbe94b2",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "464f7555-b93a-4f99-937d-d35faa4a35fa",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 4 weeks prior to randomisation and during the study."
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Atezolizumab",
        "administrableDoseForm": {
          "id": "6e581b15-21f8-4711-aae4-7c9348159553",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "c92acb47-21f5-4cf0-aa0d-b652da29bef3",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "25b937e0-3e3e-4a26-a3ee-c177c0396c14",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "60 mg/mL",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "F. Hoffmann-La Roche Ltd"
      },
      {
        "id": "prod_2",
        "name": "Placebo",
        "administrableDoseForm": {
          "id": "6e96bc4e-9356-400f-9881-ced5ecf582c9",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "6f10c735-8489-497b-b03f-02968ba10530",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "1571dd1c-843e-4efb-a6c3-e3c62a41543c",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "0 mg/mL",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "F. Hoffmann-La Roche Ltd"
      },
      {
        "id": "prod_3",
        "name": "Paclitaxel",
        "administrableDoseForm": {
          "id": "45d13af6-3aa2-4927-a331-cc39a7b414f9",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "d7d822d3-884f-48f2-bcd2-28d7ee8f9422",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "e5665cdf-7f47-4558-b2a1-99e9e30b63c9",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Atezolizumab/Placebo Regimen",
        "instanceType": "Administration",
        "dose": "840 mg",
        "doseFrequency": "Days 1 and 15 of every 28-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_2",
        "name": "Paclitaxel Regimen",
        "instanceType": "Administration",
        "dose": "90 mg/m2",
        "doseFrequency": "Days 1, 8, and 15 of every 28-day cycle",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until disease progression or end of study"
      },
      {
        "id": "admin_3",
        "name": "Dexamethasone Premedication (Oral)",
        "instanceType": "Administration",
        "dose": "8-10 mg",
        "doseFrequency": "12 and 6 hours prior to paclitaxel infusion",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Prior to first two infusions (then minimized)"
      },
      {
        "id": "admin_4",
        "name": "Dexamethasone Premedication (IV)",
        "instanceType": "Administration",
        "dose": "10 mg",
        "doseFrequency": "Within 1 hour prior to paclitaxel infusion",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "If oral dose missed"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Atezolizumab",
        "instanceType": "Substance",
        "description": "Humanised IgG1 monoclonal antibody that targets PD-L1"
      },
      {
        "id": "sub_2",
        "name": "Paclitaxel",
        "instanceType": "Substance",
        "description": "Cytotoxic chemotherapy agent"
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "PleurX",
        "instanceType": "MedicalDevice",
        "manufacturer": "Not specified"
      }
    ],
    "summary": {
      "interventionCount": 10,
      "productCount": 3,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Atezolizumab",
        "role": "Investigational Product",
        "description": "Anti-PD-L1 antibody (MPDL3280A) administered in combination with paclitaxel."
      },
      {
        "name": "Placebo",
        "role": "Placebo",
        "description": "Matching placebo consisting of the vehicle without the antibody."
      },
      {
        "name": "Paclitaxel",
        "role": "Background Therapy",
        "description": "Standard chemotherapy administered as background therapy in both study arms."
      },
      {
        "name": "Dexamethasone",
        "role": "Concomitant Medication",
        "description": "Required premedication for paclitaxel to prevent hypersensitivity reactions."
      },
      {
        "name": "Diphenhydramine",
        "role": "Concomitant Medication",
        "description": "Required premedication for paclitaxel (antihistamine)."
      },
      {
        "name": "Cimetidine",
        "role": "Concomitant Medication",
        "description": "Required premedication for paclitaxel (H2 receptor antagonist)."
      },
      {
        "name": "Ranitidine",
        "role": "Concomitant Medication",
        "description": "Alternative required premedication for paclitaxel (H2 receptor antagonist)."
      },
      {
        "name": "Chinese traditional medicines",
        "role": "Concomitant Medication",
        "description": "Permitted for China Population if last administration was at least 2 weeks prior to randomisation."
      },
      {
        "name": "Systemic immunosuppressive medications",
        "role": "Concomitant Medication",
        "description": "Prohibited within 2 weeks prior to randomisation (includes cyclophosphamide, azathioprine, cyclosporine, methotrexate, thalidomide, and anti-TNF agents)."
      },
      {
        "name": "Live, attenuated vaccine",
        "role": "Concomitant Medication",
        "description": "Prohibited within 4 weeks prior to randomisation and during the study."
      }
    ],
    "products": [
      {
        "name": "Atezolizumab",
        "doseForm": "Solution",
        "strength": "60 mg/mL",
        "manufacturer": "F. Hoffmann-La Roche Ltd"
      },
      {
        "name": "Placebo",
        "doseForm": "Solution",
        "strength": "0 mg/mL",
        "manufacturer": "F. Hoffmann-La Roche Ltd"
      },
      {
        "name": "Paclitaxel",
        "doseForm": "Solution",
        "strength": "Not specified",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Atezolizumab",
        "description": "Humanised IgG1 monoclonal antibody that targets PD-L1"
      },
      {
        "name": "Paclitaxel",
        "description": "Cytotoxic chemotherapy agent"
      }
    ],
    "administrations": [
      {
        "name": "Atezolizumab/Placebo Regimen",
        "dose": "840 mg",
        "frequency": "Days 1 and 15 of every 28-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Paclitaxel Regimen",
        "dose": "90 mg/m2",
        "frequency": "Days 1, 8, and 15 of every 28-day cycle",
        "route": "Intravenous",
        "duration": "Until disease progression or end of study"
      },
      {
        "name": "Dexamethasone Premedication (Oral)",
        "dose": "8-10 mg",
        "frequency": "12 and 6 hours prior to paclitaxel infusion",
        "route": "Oral",
        "duration": "Prior to first two infusions (then minimized)"
      },
      {
        "name": "Dexamethasone Premedication (IV)",
        "dose": "10 mg",
        "frequency": "Within 1 hour prior to paclitaxel infusion",
        "route": "Intravenous",
        "duration": "If oral dose missed"
      }
    ],
    "devices": [
      {
        "name": "PleurX",
        "manufacturer": "Not specified",
        "purpose": "Indwelling catheter for management of pleural effusion"
      }
    ]
  }
}